Apyx Medical Corporation

APYX

$3.06

-0.65%

N/A-$0.02

Salud

Médico - Especialidades

NASDAQ

Negociación activa

Apyx Medical Corporation, una empresa de tecnología energética, diseña, desarrolla, fabrica y vende equipos de electrocirugía y dispositivos médicos en Estados Unidos ...

Transacciones de insiders de APYX

Compras (A)

Since Jun 11, 2026

Ventas (D)

Since Jun 11, 2026

Acciones mensuales compradas/vendidas con tendencia del precio de cierre (fuente diaria compartida)

Resumen de trading de insiders

Fecha	Ejecutivo	Cargo	Valor	Lado	Acciones	Precio
Jun 30, 2026	Waldman Lawrence	director	Common Stock	A	12,000	$1.88
Jun 30, 2026	Waldman Lawrence	director	Common Stock	D	5,024	$4.49
Jun 30, 2026	Waldman Lawrence	director	Stock option (right to buy)	D	12,000	$1.88
Jun 15, 2026	Roman Shawn David	officer: Chief Operating Officer	Common Stock	D	10,533	$4.60
Jun 15, 2026	Roman Shawn David	officer: Chief Operating Officer	Common Stock	A	15,000	$3.23

Resumen de trading de insiders

Compras (A)

Ventas (D)

Acciones compradas totales

828,992

Acciones vendidas totales

42,557

Actividad mensual de insiders

Acciones mensuales compradas/vendidas con tendencia del precio de cierre (fuente diaria compartida)

Por cargo - Acciones

Eje X: acciones, ordenado por acciones totales desc.

Por cargo - Conteos

Eje X: conteos, ordenado por conteos A+D desc.

Personas clave: actividad de compra/venta y precio

Goodwin Charles D. II

director, officer: Chief Executive Officer • 1 transacciones

Roman Shawn David

officer: Chief Operating Officer • 4 transacciones

Waldman Lawrence

director • 3 transacciones

Levine Wendy Lauren

director • 1 transacciones

Tabla de transacciones

Fecha	Ejecutivo	Cargo	Valor	Lado	Acciones	Precio	Valor
Jun 30, 2026	Waldman Lawrence	director	Common Stock	A	12,000	$1.88	$22,560.00
Jun 30, 2026	Waldman Lawrence	director	Common Stock	D	5,024	$4.49	$22,557.76
Jun 30, 2026	Waldman Lawrence	director	Stock option (right to buy)	D	12,000	$1.88	$22,560.00
Jun 15, 2026	Roman Shawn David	officer: Chief Operating Officer	Common Stock	D	10,533	$4.60	$48,451.80
Jun 15, 2026	Roman Shawn David	officer: Chief Operating Officer	Common Stock	A	15,000	$3.23	$48,450.00
Jun 15, 2026	Roman Shawn David	officer: Chief Operating Officer	Stock option (right to buy)	D	15,000	$3.23	$48,450.00
Jun 11, 2026	Levine Wendy Lauren	director	Stock Option (Option to Buy)	A	50,000	$4.65	$232,500.00
Jun 11, 2026	Vizirgianakis Stavros G.	director	Restricted Stock Units	A	450,000	—	—
Jun 11, 2026	Goodwin Charles D. II	director, officer: Chief Executive Officer	Stock Option (Option to Buy)	A	213,948	$4.65	$994,858.20
Jun 11, 2026	Roman Shawn David	officer: Chief Operating Officer	Stock Option (Option to Buy)	A	88,044	$4.65	$409,404.60

Supply Chain de APYX

RELATIONS

Upstream

Apyx SY Medical Devices (Ningbo) Co., Ltd.Unnamed sole-source semiconductor & electronic component suppliersUnnamed helium gas suppliers (likely Air Products & Chemicals or Linde)UnconfirmedUnnamed plastics & medical-grade raw material suppliersAir Products & Chemicals, Inc.NYSE:APD Linde plcNYSE:LIN

Downstream

Symmetry Surgical (now part of Aspen Surgical Products)GlamMoon Medical Technology (division of BeauCare Clinics Investment Co., Ltd.)Duomed Group (part of Palex Medical / Apax Fremman Capital)MedShiftHologic, Inc.NASDAQ:HOLX

Sobre nosotrosPolítica de privacidadTérminos de servicioAviso legalDirectorio de accionesETFÍndicesCarteras 13FPrecios objetivoHerramientas gratuitasMapa tecnológicoÚnete a nuestro Slack

Plutux no es un asesor de inversiones. Los datos de mercado y el análisis generado por IA son solo informativos y educativos, no asesoramiento de inversión. Aviso legal